brimonidine tartrate has been researched along with dextrothyroxine in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 11 (84.62) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Fallen, RS; Gooderham, M | 1 |
| Fraser, K | 1 |
| Feldman, SR; Moustafa, FA; Sandoval, LF | 1 |
| Carter, B; Charland, L; Fedorowicz, Z; van der Linden, MM; van Zuuren, EJ | 1 |
| Draelos, ZD; Gold, LM | 1 |
| Helfrich, YR; Maier, LM | 1 |
| Keri, J | 1 |
| Fowler, JF | 1 |
| Chong, AH; Maor, D | 1 |
| Gold, LS; Gooderham, M; Johnson, S; Kerrouche, N; Lain, E; Lynde, C; Papp, K | 1 |
| Cline, A; Gomolin, T; Pereira, F | 1 |
| Bernhard, D; Clanner-Engelshofen, BM; Dargatz, S; Flaig, MJ; Gieler, U; Kinberger, M; Klövekorn, W; Kuna, AC; Läuchli, S; Lehmann, P; Nast, A; Pleyer, U; Reinholz, M; Schaller, M; Schöfer, H; Schwennesen, T; Steinhoff, M; Werner, RN; Zierhut, M | 1 |
7 review(s) available for brimonidine tartrate and dextrothyroxine
| Article | Year |
|---|---|
Rosacea: new and emerging treatments.
Topics: Administration, Cutaneous; Brimonidine Tartrate; Dermatologic Agents; Drug Design; Humans; Ivermectin; Oxymetazoline; Quality of Life; Quinoxalines; Randomized Controlled Trials as Topic; Rosacea | 2014 |
Interventions for rosacea.
Topics: Anti-Infective Agents; Brimonidine Tartrate; Cyclosporine; Dermatologic Agents; Dicarboxylic Acids; Doxycycline; Female; Humans; Ivermectin; Male; Metronidazole; Middle Aged; Ophthalmic Solutions; Quinoxalines; Randomized Controlled Trials as Topic; Rosacea; Tetracycline | 2015 |
New and Emerging Treatments for Rosacea.
Topics: Administration, Topical; Brimonidine Tartrate; Clinical Trials, Phase III as Topic; Dermatologic Agents; Dicarboxylic Acids; Drug Approval; Female; Follow-Up Studies; Forecasting; Humans; Ivermectin; Male; Oxymetazoline; Patient Satisfaction; Rosacea; Severity of Illness Index; Treatment Outcome; United States; United States Food and Drug Administration | 2015 |
Topical and oral therapeutic approach to rosacea.
Topics: Administration, Cutaneous; Administration, Oral; Brimonidine Tartrate; Dermatologic Agents; Dicarboxylic Acids; Doxycycline; Evidence-Based Medicine; Humans; Ivermectin; Metronidazole; Rosacea; Treatment Outcome | 2016 |
What's new in acne and rosacea?
Topics: Acne Vulgaris; Brimonidine Tartrate; Dapsone; Dermatologic Agents; Dermatology; Gels; Humans; Isotretinoin; Ivermectin; Rosacea; Skin Cream; Treatment Outcome | 2016 |
Rosacea First-choice treatments.
Topics: Administration, Cutaneous; Administration, Oral; Adrenergic alpha-2 Receptor Agonists; Anti-Bacterial Agents; Antiparasitic Agents; Azithromycin; Brimonidine Tartrate; Dermatologic Agents; Dicarboxylic Acids; Doxycycline; Humans; Ivermectin; Metronidazole; Rosacea | 2017 |
Treatment of rosacea during pregnancy.
Topics: Adult; Algorithms; Animals; Anti-Bacterial Agents; Azithromycin; Brimonidine Tartrate; Dermatologic Agents; Dicarboxylic Acids; Doxycycline; Female; Humans; Isotretinoin; Ivermectin; Metronidazole; Mice; Minocycline; Phototherapy; Pregnancy; Pregnancy Complications; Randomized Controlled Trials as Topic; Rosacea; Tetracyclines; Treatment Outcome | 2021 |
1 trial(s) available for brimonidine tartrate and dextrothyroxine
| Article | Year |
|---|---|
Treatment of Rosacea With Concomitant Use of Topical Ivermectin 1% Cream and Brimonidine 0.33% Gel: A Randomized, Vehicle-controlled Study.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Brimonidine Tartrate; Dermatologic Agents; Double-Blind Method; Drug Therapy, Combination; Female; Gels; Humans; Ivermectin; Male; Middle Aged; Patient Satisfaction; Rosacea; Skin Cream; Treatment Outcome; Young Adult | 2017 |
5 other study(ies) available for brimonidine tartrate and dextrothyroxine
| Article | Year |
|---|---|
Rosacea: update on management and emerging therapies.
Topics: Administration, Cutaneous; Adrenergic Agents; Anti-Infective Agents; Antiparasitic Agents; Brimonidine Tartrate; Dermatologic Agents; Dicarboxylic Acids; Doxycycline; Female; Humans; Ivermectin; Male; Metronidazole; Oxymetazoline; Quality of Life; Quinoxalines; Randomized Controlled Trials as Topic; Rosacea; Sulfacetamide; Treatment Outcome | 2012 |
72nd annual meeting of the American Academy of Dermatology.
Topics: Antifungal Agents; Attention Deficit Disorder with Hyperactivity; Boron Compounds; Botulinum Toxins, Type A; Bridged Bicyclo Compounds, Heterocyclic; Brimonidine Tartrate; Depression; Dermatitis, Atopic; Food Hypersensitivity; Humans; Immunologic Factors; Ivermectin; Phosphodiesterase Inhibitors; Phototherapy; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Quinoxalines; Skin Diseases; Societies, Medical; Thalidomide; Triazoles; United States | 2014 |
Facial Dermatitis and Rosacea.
Topics: Adrenal Cortex Hormones; Adrenergic alpha-2 Receptor Agonists; Antimicrobial Cationic Peptides; Antiparasitic Agents; Brimonidine Tartrate; Cathelicidins; Dermatitis; Dermatologic Agents; Dicarboxylic Acids; Facial Dermatoses; Humans; Ivermectin; Rosacea | 2016 |
Rosacea.
Topics: Anti-Bacterial Agents; Brimonidine Tartrate; Diagnosis, Differential; Doxycycline; Humans; Isotretinoin; Ivermectin; Laser Therapy; Metronidazole; Rosacea | 2017 |
S2k guideline: Rosacea.
Topics: Brimonidine Tartrate; Dermatologic Agents; Erythema; Humans; Ivermectin; Metronidazole; Rosacea | 2022 |